Connect your AI

Warby Parker WRBY Net Investment in Lease

Net Investment in Lease at other companies

Tarsus Pharmaceuticals, Inc.TARS

——

HRO

HarrowHROW

——

GlaukosGKOS

——

Other financials

Income statement

Revenue$242.4M+8.3%

Gross profit$131.0M+4.0%

Operating income$1.7M-32.5%

Net income$3.2M-8.5%

EPS (diluted)$0.030.0%

Balance sheet

Cash & equivalents$288.2M+8.7%

Total debt$237.6M+6.2%

Total equity$375.8M+6.1%

Total assets$736.4M+7.9%

Cash flow

Operating cash flow$24.5M-16.5%

CapEx$16.1M-0.1%

Free cash flow$8.4M-36.6%

Valuation

Market cap$3.15B+17.1%

Profitability

Gross margin53.4%-1.8pp

Operating margin-0.7%-0.3pp

Net margin0.1%0.0pp

FCF margin4.5%-0.8pp

Returns & leverage

Return on equity0.2%+0.1pp

Debt / equity0.6×0.0×

Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Warby Parker's net investment in lease?: Warby Parker (WRBY) reported net investment in lease of $175.27M in Q1 2026.
How has Warby Parker's net investment in lease changed year-over-year?: Warby Parker's net investment in lease increased by 3.0% year-over-year, from $170.19M to $175.27M.